Reneo Cash from 2010 to 2024
RPHM Stock | USD 1.66 0.06 3.49% |
Cash | First Reported 2010-12-31 | Previous Quarter 27.6 M | Current Value 38.9 M | Quarterly Volatility 28.4 M |
Check Reneo Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Reneo main balance sheet or income statement drivers, such as Net Interest Income of 24.8 K, Interest Income of 24.8 K or Depreciation And Amortization of 551.2 K, as well as many exotic indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.58. Reneo financial statements analysis is a perfect complement when working with Reneo Pharmaceuticals Valuation or Volatility modules.
Reneo | Cash |
Latest Reneo Pharmaceuticals' Cash Growth Pattern
Below is the plot of the Cash of Reneo Pharmaceuticals over the last few years. Cash refers to the most liquid asset of Reneo Pharmaceuticals, which is listed under current asset account on Reneo Pharmaceuticals balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Reneo Pharmaceuticals customers. The amounts must be unrestricted with restricted cash listed in a different Reneo Pharmaceuticals account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. Reneo Pharmaceuticals' Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Reneo Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Cash | 10 Years Trend |
|
Cash |
Timeline |
Reneo Cash Regression Statistics
Arithmetic Mean | 29,318,352 | |
Geometric Mean | 23,575,093 | |
Coefficient Of Variation | 96.73 | |
Mean Deviation | 17,233,497 | |
Median | 17,501,000 | |
Standard Deviation | 28,360,241 | |
Sample Variance | 804.3T | |
Range | 107.2M | |
R-Value | 0.43 | |
Mean Square Error | 707.5T | |
R-Squared | 0.18 | |
Significance | 0.11 | |
Slope | 2,713,978 | |
Total Sum of Squares | 11260.2T |
Reneo Cash History
Other Fundumenentals of Reneo Pharmaceuticals
Reneo Pharmaceuticals Cash component correlations
Click cells to compare fundamentals
About Reneo Pharmaceuticals Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Reneo Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Reneo Pharmaceuticals investors use historical funamental indicators, such as Reneo Pharmaceuticals's Cash, to determine how well the company is positioned to perform in the future. Although Reneo Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Reneo Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Reneo Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Reneo Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Reneo Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Reneo Pharmaceuticals using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out the analysis of Reneo Pharmaceuticals Correlation against competitors. To learn how to invest in Reneo Stock, please use our How to Invest in Reneo Pharmaceuticals guide.Note that the Reneo Pharmaceuticals information on this page should be used as a complementary analysis to other Reneo Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for Reneo Stock analysis
When running Reneo Pharmaceuticals' price analysis, check to measure Reneo Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reneo Pharmaceuticals is operating at the current time. Most of Reneo Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Reneo Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reneo Pharmaceuticals' price. Additionally, you may evaluate how the addition of Reneo Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |
Is Reneo Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Reneo Pharmaceuticals. If investors know Reneo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Reneo Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.17) | Return On Assets (0.52) | Return On Equity (0.84) |
The market value of Reneo Pharmaceuticals is measured differently than its book value, which is the value of Reneo that is recorded on the company's balance sheet. Investors also form their own opinion of Reneo Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Reneo Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Reneo Pharmaceuticals' market value can be influenced by many factors that don't directly affect Reneo Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Reneo Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Reneo Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Reneo Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.